Fact Corp/ US3030392001 /
2019-09-17 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0008USD | - | 13,500 Turnover: - |
-Bid Size: - | -Ask Size: - | 0.0008 | 0.0008 |
Newsfile Corp
10-18
RLF Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in ...
GlobeNewswire
08-30
Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
08-28
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposur...
GlobeNewswire
08-27
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COV...
Newsfile Corp
08-21
Substantial Increase in Deaths Among Young Off-Road Vehicle Riders in Past Two Decades Highlights Ne...
GlobeNewswire
08-19
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf Ardelyx, Inc. (ARDX) Investors – Holzer & Ho...
GlobeNewswire
08-16
Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
08-15
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% ...
GlobeNewswire
08-15
Odysight.ai Reports Financial Results for the First Half of 2024 and Provides Business Update
GlobeNewswire
08-14
Small Dollar Lending and Lending to Underserved Entrepreneurs Continues to Rise as a Record 19 Milli...
GlobeNewswire
08-14
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
GlobeNewswire
08-13
MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Techn...
GlobeNewswire
08-09
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
08-09
MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dis...